Market Analysis and Price Projections for NDC 69452-227: Amphetamine Sulfate
Introduction to Amphetamine Sulfate
Amphetamine Sulfate, identified by the National Drug Code (NDC) 69452-227, is a central nervous system stimulant used primarily for the treatment of attention deficit hyperactivity disorder (ADHD) and certain cases of narcolepsy. It is distributed by Bionpharma Inc. and was approved for marketing on January 15, 2020[1].
Market Context
Pharmaceutical Market Trends
The pharmaceutical market is subject to various factors that influence drug prices. According to Vizient's summer Pharmacy Market Outlook for 2024, the overall drug price inflation rate for pharmaceuticals in 2025 is projected to be 3.81%. This projection is influenced by factors such as the expanding indications of previously approved medications and the introduction of high-cost cell and gene therapies[2].
Drug Price Fluctuations
Historical data on drug price fluctuations indicates that changes are often infrequent. A study by the Office of Inspector General (OIG) found that only about 1% of drug prices changed in most weeks, with the average median increase in price being approximately 7% in any given week. However, significant decreases can also occur, with median decreases exceeding 15% in some periods[3].
Pricing Factors for Amphetamine Sulfate
Regulatory Environment
The pricing of Amphetamine Sulfate is influenced by regulatory requirements. The FDA's National Drug Code Directory ensures that all drugs, including Amphetamine Sulfate, are identified and reported using a unique NDC number. This helps in tracking and regulating drug prices[4].
Supply Chain Dynamics
The pharmaceutical supply chain, including interactions between manufacturers, pharmacy benefit managers (PBMs), and health insurers, plays a crucial role in determining drug prices. Oregon's Drug Price Transparency Program highlights the complexity of these interactions and the need for transparency across the supply chain to understand the factors influencing drug costs[5].
Price Projections for Amphetamine Sulfate
General Trends
Given the projected 3.81% overall drug price inflation rate for 2025, it is reasonable to expect that the price of Amphetamine Sulfate could increase by a similar margin. However, this is a general trend and may not reflect the specific dynamics of this drug.
Specific Factors
- Demand and Supply: Changes in demand due to new treatment guidelines or shifts in patient populations can impact pricing.
- Competitive Landscape: The presence of other ADHD medications and their pricing strategies can influence the price of Amphetamine Sulfate.
- Regulatory Changes: Any changes in regulatory requirements or transparency laws could affect pricing.
Potential Price Scenarios
Conservative Estimate
A conservative estimate would align with the general inflation rate, suggesting a price increase of around 3.81% for Amphetamine Sulfate in 2025.
Moderate Estimate
Considering the specific factors influencing Amphetamine Sulfate, such as changes in demand or competitive pressures, the price could increase by 5-7%. This is slightly higher than the general inflation rate due to the drug's niche market and potential demand fluctuations.
High Estimate
In a scenario where there are significant changes in the regulatory environment or a substantial increase in demand, the price could rise more sharply, potentially exceeding 10%.
Key Takeaways
- General Inflation: The overall drug price inflation rate for 2025 is projected at 3.81%.
- Regulatory Influence: FDA regulations and transparency laws impact drug pricing.
- Supply Chain Dynamics: Interactions between various entities in the pharmaceutical supply chain influence drug costs.
- Specific Factors: Demand, supply, competitive landscape, and regulatory changes can affect the price of Amphetamine Sulfate.
FAQs
Q1: What is the current NDC for Amphetamine Sulfate?
- The NDC for Amphetamine Sulfate is 69452-227[1].
Q2: Who is the labeler for Amphetamine Sulfate?
- The labeler for Amphetamine Sulfate is Bionpharma Inc.[1].
Q3: What is the projected overall drug price inflation rate for 2025?
- The projected overall drug price inflation rate for 2025 is 3.81% according to Vizient's summer Pharmacy Market Outlook[2].
Q4: What factors influence the price of Amphetamine Sulfate?
- The price of Amphetamine Sulfate is influenced by demand and supply dynamics, the competitive landscape, and regulatory changes[5].
Q5: How often do drug prices typically change?
- Drug prices typically change infrequently, with only about 1% of prices changing in most weeks[3].
Sources
- FDA.report: NDC 69452-227 Oral Tablet Amphetamine Sulfate.
- Vizient Inc.: Vizient projects drug price inflation at 3.81%.
- OIG: Temporary Medicare-Approved Drug Discount Card: Analysis of Drug Prices.
- FDA: National Drug Code Directory.
- Oregon Department of Consumer and Business Services: Prescription Drug Price Transparency Results and Recommendations.
